Thoracic Surgery Devices Market Size Analysis, Growth Trends & Forecast to 2034

Thoracic Surgery Devices Market Overview

The global thoracic surgery devices market was valued at USD 11.7 billion in 2026 and is projected to reach USD 22.1 billion by 2034, expanding at a CAGR of 8.8% during the forecast period. Demand for thoracic surgery devices is expected to grow faster due to increases in lung cancer and diseases of the esophagus and other thoracic organs. Demand is expected to grow with the number of thoracic surgeries performed worldwide. More thoracic surgery devices are used with more surgeries performed. Demand for devices is also expected to increase with the adoption of less invasive surgeries, such as video-assisted thoracoscopic surgery (VATS), robot-assisted thoracic surgery (RATS), and other procedures. This translates into greater demand for advanced surgical staplers, endoscopic imaging devices, energy devices, and other robot-assisted devices that make surgery easier and faster for patients.

Thoracic Surgery Devices Market Drivers and Opportunities

Rising Prevalence of Thoracic Diseases is Driving Market Growth

The rising prevalence of lung cancer and other thoracic diseases is expected to drive the thoracic surgery devices market. Many patients diagnosed with lung cancer require multiple surgeries due to the disease being one of the top cancer diagnoses and deaths worldwide. Projections by the American Cancer Society predict an additional 229,410 lung cancer diagnoses and an additional 124,990 deaths due to lung cancer in the United States in 2026. These statistics emphasize the high burden of disease and the high need for surgical interventions. The increased incidence of other diseases, such as cancers of the esophagus, chronic obstructive pulmonary disease (COPD), pulmonary infections, and other disorders of the mediastinum, has increased the need for thoracic surgery worldwide. More surgeries are in demand due to the increased incidence of thoracic diseases in the elderly. Advances in low-dose CT scans and molecular diagnostics have improved the early detection of thoracic diseases and the ability for curative surgical procedures. These factors have increased the demand for better thoracic surgery devices. Hospitals and specialty thoracic surgery centers are purchasing surgery devices, such as powered staplers, energy-based vessel sealing devices, and high-definition endoscopic imaging devices, to improve surgical outcomes.

Growing adoption of minimally invasive and robotic-assisted surgery Fueling Market Expansion

The demand for advanced thoracic surgery devices is growing very fast. VATS and RATS are the best way to treat lung cancer, esophageal problems, and other thoracic conditions because they're less invasive, have less blood loss, less pain, shorter hospital stays, and faster recovery compared to open surgery. This has led to a greater demand for specialized endoscopes, powered surgical staplers, high-definition visualization systems, energy-based tissue sealing devices, and robotic surgical platforms. Advancements in technology, including 3D imaging, fluorescence-guided visualization, articulating instruments, and AI-assisted surgical planning, are continuing to improve. Hospitals and healthcare systems are also investing in new operating rooms and robotic surgery programs. As surgeon expertise in minimally invasive techniques grows and patients prefer less invasive surgeries, adoption of next-generation thoracic surgery devices is expected to increase.

Expansion of robotic and AI-enabled thoracic surgery in emerging markets Presents Significant Opportunities

Developing countries have great potential for the growth of the market for thoracic surgery devices due to improvements in health care and investments in advanced technologies. Governments and private hospitals are expanding centers for specialized thoracic surgery and equipping hospitals with modern operating rooms for minimally invasive and robotic surgeries. With more doctors realizing the benefits of robotic surgery, such as being more precise, having better vision, and having fewer complications, doctors and surgeons are looking towards newer generations of robotic surgical systems. At the same time, the use of artificial intelligence for surgical planning, during surgery, workflow improvement, and predictive analysis is improving surgeries. Moreover, training programs for surgeons and partnerships between device manufacturers and hospitals are also increasing the number of surgeons who are skilled at performing advanced thoracic procedures. With reimbursement policies changing and access to advanced surgical technology becoming more common, companies have the opportunity to create low-cost thoracic surgery machines.

Thoracic Surgery Devices Market Scope

Thoracic Surgery Devices Market Report Segmentation Analysis

The global thoracic surgery devices market industry analysis is segmented by procedure type, by product type, by indication, by end user, and by region.

Video-Assisted Thoracoscopic Surgery Segment Is Expected to Dominate the Thoracic Surgery Devices Market During the Forecast Period

Video-Assisted Thoracoscopic Surgery (VATS) is expected to be the dominant segment in the global thoracic surgery devices market during the forecast period owing to the increasing trend of minimally invasive surgeries resulting in fewer complications, faster recovery, reduced postoperative pain, and shorter hospital stays compared to traditional open thoracic surgery. Growing use of VATS in lung cancer, pulmonary nodules, and other thoracic diseases is driving demand for thoracic surgery devices such as endoscopic staplers, energy-based sealing devices, thoracoscopes, and HD cameras. This trend was substantiated by a meta-analysis conducted in September 2025, which revealed that the survival rate among patients who underwent Video-Assisted Thoracoscopic Surgery (VATS) for lobectomy was much better compared to the survival rate of those who underwent open lobectomy. Such a favorable clinical outcome is encouraging surgeons and other healthcare professionals to opt for VATS as the better surgical procedure for such patients. In addition, continued advancements in the field of thoracoscopic visualization, motorized surgical instruments, and surgical education have led to the increasing acceptance of VATS across the globe.

Robotic Platforms Segment Is Expected to Lead the Thoracic Surgery Devices Market by Product Type

The segment of robotic platforms is expected to dominate the market in terms of product type during the forecast period owing to the rising prevalence of robot-assisted thoracic surgery (RATS), which is being used in complex pulmonary, mediastinal, and esophageal surgeries. Robotic platforms offer enhanced three-dimensional visualization, enhanced dexterity of the instruments, tremor filtration, and precision to the surgeons, which enable them to dissect and suture accurately within the thoracic cavity. This enables reduced blood loss, fewer complications after the surgery, shorter hospital stays, and quicker recovery of the patients than conventional open surgery while also expanding the scope of minimally invasive procedures. The rising incidence of lung cancer and other thoracic disorders, along with the increasing preference for minimally invasive surgical procedures, has been driving the uptake of robotic-assisted surgery procedures. Moreover, advancements like AI-assisted visualization, fluorescence-guided visualization, improved robotic instruments, and enhanced ergonomic surgeon consoles are contributing towards increased efficiency of the procedure. The rising investment by hospitals in advanced surgical equipment, increasing reimbursement in developed regions, and training of the surgeons have been contributing to the dominance of the segment of robotic platforms.

Lung Cancer Segment Is Expected to Dominate the Indication Segment

The lung cancer segment will account for the largest share of the thoracic surgery devices market by indication, owing to the high burden of the disease globally and increasing use of surgery for the treatment of early-stage disease. Lung cancer is expected to remain the dominant indication among thoracic procedures, including lobectomy, segmentectomy, and wedge resection, requiring advanced surgical devices. As per the data published by the American Cancer Society, there are about 229,410 new lung cancer cases and 124,990 deaths caused by the disease in 2026 in the US alone. Besides, the growing adoption of low-dose CT screenings, increasing usage of minimally invasive approaches like VATS and robotic thoracic surgery, and continuous developments in surgical device technology are further reinforcing the dominant position of the lung cancer segment in the thoracic surgery devices market.

Hospitals Segment Is Expected to Dominate the End User Segment

The hospitals segment will hold a dominant position in the thoracic surgery devices market by end user in the coming years, owing to the high incidence of thoracic surgeries and the presence of highly sophisticated infrastructure for conducting such surgeries in hospitals. Hospitals form the main venues for the conduct of complicated surgeries, including those of lung cancer, esophageal cancer, and mediastinal surgeries. In addition, the increasing trend of minimally invasive thoracic and robot-assisted thoracic surgeries, along with the rising investment in high-resolution image system technology, robotic systems, and powered surgical instruments, will help drive the demand from hospitals. Apart from this, other factors such as a positive reimbursement policy, development of health care infrastructure, and a rising number of thoracic disease cases will continue to favor the growth of the hospital segment.

The following segments are part of an in-depth analysis of the global thoracic surgery devices market:

Thoracic Surgery Devices Market Share Analysis by Region

North America is projected to hold the largest share of the global thoracic surgery devices market over the forecast period.  

North America is set to dominate the global market for thoracic surgery devices owing to the presence of higher rates of thoracic diseases, an advanced healthcare infrastructure, adoption of minimally invasive thoracic surgeries, and prominent medical device makers in the region. A favorable reimbursement landscape and increased spending on the healthcare sector are other factors driving the regional market growth. As a testament to the region's performance, in January 2026, Able Medical marked the milestone of completion of its 10,000^th procedure in the U.S. using its Valkyrie Thoracic Fixation System, which is used for sternal closure and chest wall stabilization through advanced thoracic fixation technologies. Rising incidences of lung cancer, proliferation of thoracic surgery centers, and innovations in surgical devices will ensure North America's dominance in the global thoracic surgery devices market during the forecast period.

Thoracic Surgery Devices Market Competition Landscape Analysis

The thoracic surgery devices market features key medical device vendors focused on innovation in minimally invasive and robotic-assisted surgical devices, thoracoscopic devices, endoscopy devices, surgical staples, energy-based devices, and thoracic fixation devices. The key players are leveraging their competitive edge through innovation in their product portfolio, partnerships, M&A activities, regulatory approvals, geographical expansions, and investments in R&D. Moreover, the increasing use of video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracoscopic surgery (RATS), advanced surgical imaging, enhanced recovery processes, and the rising incidence of various thoracic ailments, including lung cancer and esophageal ailments, represent substantial growth prospects for the worldwide thoracic surgery devices market. 

Global Thoracic Surgery Devices Market Recent Developments News:

●        In January 2026, Johnson & Johnson announced that it had submitted the OTTAVA Robotic Surgical System to the U.S. Food and Drug Administration (FDA) for De Novo classification.

●        In March 2025 - Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced the launch of its first AI-powered clinical decision tool through a strategic partnership with software firm Ziosoft. The first three applications being launched aim to revolutionize liver, lung, and kidney procedures, thoracic surgery, liver surgery, and urologic surgery.

●        In May 2025 - Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) technology, announced that its Nanosecond PFA technology was featured in a presentation and a preclinical poster featuring the nsPFA Cardiac Surgical System at the American Association for Thoracic Surgery (AATS) 2025 Annual Meeting, being held May 2-5 in Seattle, Washington.

The global thoracic surgery devices market is dominated by a few large companies, such as

●        B. Braun Melsungen AG

●        Boston Scientific Corporation

●        CONMED Corporation

●        CooperSurgical, Inc.

●        Delacroix-Chevalier

●        Fujifilm Holdings Corporation

●        Getinge AB

●        Intuitive Surgical

●        Johnson & Johnson (Ethicon)

●        Karl Storz SE & Co. KG

●        KLS Martin Group

●        Medtronic plc

●        MicroPort Scientific Corporation

●        Olympus Corporation

●        Richard Wolf GmbH

●        Scanlan International

●        Stryker Corporation

●        Teleflex Incorporated

●        XION GmbH

●        Other Prominent Players